survival nor in rate or degree of improvement in the survivors of the haemodiluted group.
Dr Candelise's study was also multicentre and some 1200 patients were investigated. Here haematocrit was reduced to about 35% in 24 h, again normovolaemically by venesection and dextran-solution addition. However, as in the last study, no improvement was discernible from this procedure, and this still obtained when the patient data was analysed separately for those with infarcts and those with haemorrhagic stroke.
In his paper Dr J P G Wade (Charing Cross Hospital, London) described the result of a study of 1377 patients with symptomatic obstructive cerebrovascular disease. These patients were randomized to either medical or surgical (extracranial-intercranial bypass) therapy, and were followed for an average of 56 months. Their outcome was compared with haemoglobin estimates performed at entry. In the medical group there was no difference in the incidence of stroke in those with haemoglobin above 15 gldl compared with those below this haemoglobin level, nor were the strokes more severe. Haemoglobin was also not a prognostic factor in the surgically treated patients. Hence haemoglobin concentration again does not seem to be associated with poor outcome in patients with symptomatic obstructive disease of the carotid or cerebral arteries.
In his paper Dr P N Rogers (Gartnavel General Hospital, Glasgow) studied whole blood viscosity, haematocrit, plasma viscosity and fibrinogen levels in 50 patients with transient ischaemia attacks (TIA), 20 with intermittent claudication and 64 controls. While whole blood viscosity was highest in the claudicants, there was no significant difference between the TIA and control groups. Plasma viscosity and fibrinogen were higher in both TIA and claudicant groups than in the controls. The highest values in TIA patients were seen in those with internal carotid diseases demonstrable by Doppler Scanning. Haematocrit, however, was again not different between the control and TIA groups. Nevertheless, clearly there was a rheological association with each of the diseased groups.
Dr D J Thomas (St Mary's Hospital, London) described the preliminary results in the UK TIA aspirin trial. Nearly 2500 patients had been followed for up to 8 years. They had presented with transient cerebral ischaemic attacks, amaurosis fugax or very minor stroke. One third of the patients were taking placebo, one third were on low dose aspirin (300 mg) and the remaining third were on high dose aspirin (1200 mg), Patients with anaemia and polycythaemia were excluded from the study. Taking the population as a whole, there was no obvious increased risk from stroke, myocardial infarction or vascular death with increasing haematocrit. However, when the placebo group was studied separately it was found that they had significantly greater risk of developing myocardial infarcted stroke or vascular death with increasing haematocrit. Somehow, therefore, aspirin seemed to negate the harmful effects observed in epidemiological studies of haemoglobin and haematocrit. Presumably, aspirin exerts this protection via its known antiplatelet effect. It is possible that the harmful effects of high haematocrit are through the influence of increased red cell numbers enhancing the activation of platelets rather than via the increase in whole blood viscosity.
There was an air of disappointment surrounding this meeting. The findings in the literature that haemoglobin concentration correlates with the incidence of stroke had held out the possibility of its manipulation being a clinically beneficial technique. However, the results reported here would seem to negate this. Nevertheless, there is still strong evidence of rheological association with stroke incidence, possibly relating to interaction with platelets; there are alterations in leucocyte and erythrocyte concentrations and mechanics, and good reasons for expecting these to be of causal significance. Clearly there are complex interactions involved here, and more studies are required to elucidate the situation. Dr Patrick Pietroni, one of the founders of the Marylebone Health Centre, is a frequent speaker on occasionswhere complementary medicine is discussed; and he said he was tired of forever giving much the same speech about his work. So this time (after telling us how his time in the USA had caused him to become interested in holistic medicine, and how he had started a unit based at St Mary's which he described as 'an experiment in medical anthropology') he treated the section to a new idea: that there should be a basic core curriculum which anybody practising any sort of medicine needed to learn.
M W Rampling
It came out, not as the three R's, but as the 10 Cs. First came the context in which the patient felt himself to be ill; he felt treatment had to be given in the same cultural context as the patient if it was to do any good. Communication was, inevitably, the second; third came the difference between caring and curing; and then the need to be critical of your own limitations.
He discussed the question of control, and said it was not always in the patient's interest to let him have total control -he may need his illness, need to let go of his autonomy. The other C's were the importance of being a catalyst, of understanding compromisetotal excellence just isn't always achievable; a recognition of the normal ups and downs of the cycles of health; and he finished on the need for curiosity.
Mr Roger Newman Turner is, among other things, a naturopath but very familiar with a wide range of complementary therapies and so peculiarly well qualified to speak on hopes that 'there's a place for us' in the NHS. He did not, however, go into many details of integration; rather he tried to explain many of the important elements in complementary medicine which make it an interesting useful adjunct to the orthodox. He took us, for example, through Hering's theory of cure, based on the concept that all cure comes from within; he discussed the unitary theory of McDonagh and other contenders -not all successfulfor credibility. Interestingly, he put paid to one widely held explanation for the efficacy of alternative techniques: that it is the impact of the practitioner which counts, that it is 'all in the mind'. Not so, says Mr Turner, the treatment matters most; he cited such examples as the use of acupuncture for pain relief in those with 'no-hope' diagnoses of spinal arthritis.
He, like the previous speaker, stressed the need for a basic training for everyone involved with patients, and looked forward to a scene where a patient was enabled to make an informed choice between various different methods of treatment. Research, he felt, was needed to refine therapeutic techniques, and to establish credibility for some disciplines currently Journal of the Royal Society of Medicine Volume 81 October 1988 615 outside orthodox medicine. There was, however, an increasing place for 'safe non-invasive and non-toxic solutions' to patients' ills. The meeting was enhanced by his selection of slides, which included not only beautiful pictures of some of the herbs used in therapy, but a cartoon of lemmings heading for a cliff, being talked out of it by the Samaritans.
Dr John Barlow is a north London GP who knows a good deal about 'alternative' practices: he goes to an osteopath himself and has read most of Dr Pietroni's work -much of which he disagrees with. He completed the triangular pattern of the meeting by playing devil's advocate. Deeply doubtful about holistic medicine -'a loose, well-meaning philosopy' -as any sort of substitute for the conventional kind, he also saw plenty of purely procedural snags. What about registration? How about liability? Who would insure the practitioners against malpractice suits -not, he had established, the Medical Defence Union? If a GP has to operate among a welter of different therapies, how will he know, for example, which herbal remedies should not be prescribed for a pregnant woman? He felt that cheap 'holistic' medicine could all too easily be offered to a gullible public in place of what they were entitled to; as 'a third world system for the first world' -simply because of its low cost: and finished with a salutary reminder of just how good a system our NHS can be.
On closing the meeting, Sir James Watt reminded us that the care of the patient was only equalled in importance by the need for the protection of the patient; and that the only complementary therapies likely to be involved in any sort of respectable relationship with orthodox medicine were the 6 that have stringent training programs of their own: homoeopathy, herbalism, acupuncture, osteopathy, chiropractic and naturopathy. Neither the NHS or anybody else was about to open the door to any 'alternative' that offerred. The evening had provided an enormous amount of food for thought, for a larger than usual audience; it was only a pity that there was, in the end, no time for discussion before the actual food was ready.
Katharine Whitehorn
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Future developments in orthopaedic radiology
Keywords: biopsy; magnetic reasonance imaging; bone tumours A joint meeting of the Section of Radiology and Orthopaedics was jointly chaired by the respective Presidents. Miss Irene Cade introduced the Finzi Lecturer, Dr Helge Johansen from Denmark who described the work done in the two treatment centres on 87 cases of EwiI!g's Sarcoma of Bone, a remarkable number of cases of this rare tumour.
Mr Brian Andrews then introduced the Orthopaedic team. Dr Dennis Stoker (Radiologist, Royal National Orthopaedic Hospital) talked about the need for biopsy of undiagnosed lesions of bone. The value of needle biopsy undertaken by a radiologist with imaging control was emphasized by the complication rate of 0.2%, compared with a reported complication rate of 17.3%with open biopsy. In reporting a personal series of vertebral biopsies in 135 patients, a failure to make a diagnosis in 11.1% was mainly due to inadequate material, corrected by a repeat procedure. He stressed the great value of histocytochemistry and other new pathological techniques which were possible on imprint preparations made at the time of the core biopsy. He considered that the technique 
